1. Regulation of T cell receptor signaling by protein acyltransferase DHHC21
- Author
-
Darren Boehning, Ying Fan, Ritika Tewari, Askar M. Akimzhanov, and Bieerkehazhi Shayahati
- Subjects
0301 basic medicine ,Cell signaling ,T cell receptor complex ,Acylation ,T-Lymphocytes ,T cell ,Receptors, Antigen, T-Cell ,Lipid-anchored protein ,Article ,03 medical and health sciences ,Protein acylation ,0302 clinical medicine ,Downregulation and upregulation ,Genetics ,medicine ,Animals ,Protein palmitoylation ,Molecular Biology ,Cells, Cultured ,030304 developmental biology ,0303 health sciences ,Effector ,Chemistry ,T-cell receptor ,General Medicine ,Cell biology ,Mice, Inbred C57BL ,030104 developmental biology ,medicine.anatomical_structure ,Acyltransferases ,030220 oncology & carcinogenesis ,Signal transduction ,Signal Transduction ,030215 immunology ,Cysteine - Abstract
S-acylation – reversible post-translational lipidation of cysteine residues – is emerging as an important regulatory mechanism in T cell signaling. Dynamic S-acylation is critical for protein recruitment into the T cell receptor complex and initiation of the subsequent signaling cascade. However, the enzymatic control of protein S-acylation in T cells remains poorly understood. Here, we report a previously uncharacterized role of DHHC21, a member of the mammalian family of DHHC protein acyltransferases, in regulation of the T cell receptor pathway. We found that loss of DHHC21 prevented S-acylation of key T cell signaling proteins, resulting in disruption of the early signaling events and suppressed expression of T cell activation markers. Furthermore, downregulation of DHHC21 prevented activation and differentiation of naïve T cells into effector subtypes. Together, our study provides the first direct evidence that DHHC protein acyltransferases can play an essential role in regulation of T cell-mediated immunity.
- Published
- 2020